Welcome to BeiMedPlus

On BeiMedPlus you will find information for healthcare professionals in the United States on BeiGene products, clinical development pipeline, clinical trials, scientific congress data, publications and other resources.

American Society of Hematology

ASH 2024

December 07-10,2024

San Diego Convention Center, San Diego

Explore ASH 2024 resources

Zanubrutinib

Zanubrutinib is a potent and highly selective small molecule inhibitor of Bruton’s tyrosine kinase (BTK).

Learn more about zanubrutinib

Welcome to BeiMedPlus

On BeiMedPlus you will find information for healthcare professionals in the United States on BeiGene products, clinical development pipeline, clinical trials, scientific congress data, publications and other resources.

Congress Resources

Access English-language abstracts, posters, and presentations presented at medical congresses around the world.

Publications

Access links to peer-reviewed scientific literature for educational purposes and explore the latest data from medical congresses around the world.

Pipeline

Browse BeiGene’s pipeline of novel investigational molecules to treat cancer.

Molecules

Learn more about the mechanism of action of BeiGene’s molecules. Dive into the specific pathways and molecular interactions to learn more about their potential in hematologic malignancies and solid tumors.

Clinical Trials

Explore results from some of BeiGene’s clinical trials.